A commercial-stage biotechnology company focused on therapies for acute pain management and chemotherapy-induced nausea and vomiting. Its portfolio includes non‑opioid post‑surgical pain treatment Zynrelef and antiemetic drugs such as Cinvanti, with revenue tied to hospital and oncology clinic adopt...
1 member of Congress has disclosed 3 trades in Heron Therapeutics, Inc. (APPAD), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-05-18 | Tom Malinowski | sell | $15K – $50K |
| 2020-12-30 | Tom Malinowski | sell | $1K – $15K |
| 2020-12-11 | Tom Malinowski | sell | $1K – $15K |